2023 - Research.com Medicine in Sweden Leader Award
His scientific interests lie mostly in Internal medicine, Myocardial infarction, Cardiology, Cardiopulmonary resuscitation and Surgery. His research on Internal medicine often connects related areas such as Diabetes mellitus. His research in the fields of Infarction overlaps with other disciplines such as In patient.
The study incorporates disciplines such as Relative risk and Lidocaine in addition to Cardiology. His biological study spans a wide range of topics, including Out of hospital, Survival analysis and Ventricular fibrillation. His Surgery research is multidisciplinary, incorporating perspectives in Myocardial infarction complications, Coronary care unit, Predictive value of tests and Tachycardia.
His primary areas of investigation include Internal medicine, Myocardial infarction, Cardiology, Surgery and Emergency medicine. His work on Diabetes mellitus expands to the thematically related Internal medicine. The various areas that Johan Herlitz examines in his Myocardial infarction study include Mortality rate, Anesthesia, Metoprolol and Chest pain.
His work on Electrocardiography, Coronary artery disease and Coronary heart disease as part of general Cardiology study is frequently linked to In patient, bridging the gap between disciplines. His research brings together the fields of Heart disease and Surgery. His research in Emergency medicine intersects with topics in Coronary care unit and Emergency department.
His primary areas of study are Emergency medicine, Internal medicine, Cardiopulmonary resuscitation, Out of hospital cardiac arrest and Cardiology. Johan Herlitz has included themes like Anxiety, Socioeconomic status, Incidence and Medical emergency in his Emergency medicine study. His study on Internal medicine is mostly dedicated to connecting different topics, such as Anesthesia.
His Cardiopulmonary resuscitation study integrates concerns from other disciplines, such as Psychological intervention, Emergency medical services, Defibrillation and Intensive care medicine. Cardiology is represented through his Percutaneous coronary intervention, Cardiogenic shock and Heart failure research. His study on Myocardial infarction also encompasses disciplines like
The scientist’s investigation covers issues in Cardiopulmonary resuscitation, Out of hospital cardiac arrest, Intensive care medicine, Emergency medical services and Emergency medicine. His Cardiopulmonary resuscitation study combines topics from a wide range of disciplines, such as Defibrillation, Logistic regression, Etiology and Ventricular fibrillation. His work deals with themes such as Guideline, Epidemiology and Basic life support, which intersect with Out of hospital cardiac arrest.
His studies deal with areas such as Retrospective data, Prospective cohort study and Retrospective cohort study as well as Emergency medical services. His study in Emergency medicine is interdisciplinary in nature, drawing from both Patient safety and Inpatient care. His In patient studies intersect with other subjects such as Myocardial infarction, Cardiology and Internal medicine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)
A. Hjalmarson;S. Goldstein;B. Fagerberg;H. Wedel.
The Lancet (1999)
Indications for fibrinolytic therapy in suspected acute myocardial infarction : collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
The Lancet (1994)
Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year
Klas Malmberg;Lars Rydén;Suad Efendic;Johan Herlitz.
Journal of the American College of Cardiology (1995)
Effects of Controlled-Release Metoprolol on Total Mortality, Hospitalizations, and Well-being in Patients With Heart Failure: The Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF)
A. Hjalmarson;S. Goldstein;B. Fagerberg;H. Wedel.
Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity
K Malmberg;Lars Rydén;H Wedel;K Birkeland.
European Heart Journal (2005)
Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial.
Å Hjalmarson;Johan Herlitz;I Málek;L Rydén.
The Lancet (1981)
Incidence of EMS-treated out-of-hospital cardiac arrest in Europe
Christie Atwood;Mickey S. Eisenberg;Mickey S. Eisenberg;Johan Herlitz;Thomas D. Rea;Thomas D. Rea.
N-Terminal Pro-B–Type Natriuretic Peptide and Long-Term Mortality in Acute Coronary Syndromes
Torbjørn Omland;Anita Persson;Leong Ng;Russel O’Brien.
Early Cardiopulmonary Resuscitation in Out-of-Hospital Cardiac Arrest
Ingela Hasselqvist-Ax;Gabriel Riva;Johan Herlitz;Mårten Rosenqvist.
The New England Journal of Medicine (2015)
Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo-controlled international trial
Johan Herlitz;Å Hjalmarson.
European Heart Journal (1985)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: